Detection of antibodies to L1, L2, and E4 proteins of human papillomavirus types 6, 11, and 16 by ELISA using synthetic peptides

Antibodies against eight synthetic peptides spanning different epitopes located on L1, L2, and E4 proteins of human papillomavirus (HPV) types 16, 6, and 11 were examined in sera from 73 women infected by HPV and from 139 healthy controls. Only three of these peptides were reactive. Two located on proteins L2 and E4 of HPV 16 seem type specific since antibodies to these peptides were detected, respectively, in 21% and 15% of the HPV 16 infected patients and in 2.5% and none of women infected by other HPVs. The third peptide located on the L1 protein of HPV 6 bears a common epitope since antibodies to this peptide were detected not only in 85% of women infected by HPV 6 or 11, but also in 82% of women infected by other HPVs, and in 74% and 71% of the control groups (10–12‐year‐old children and adults, respectively). In conclusion, none of the peptides investigated seems useful to develop ELISAs for serological diagnosis of HPV infection. © 1995 Wiley‐Liss, Inc.

[1]  B. Yvonnet,et al.  Twelve-year follow-up study of hepatitis B immunization of Senegalese infants. , 1994, Journal of hepatology.

[2]  D. Lowy,et al.  Efficient self-assembly of human papillomavirus type 16 L1 and L1-L2 into virus-like particles , 1993, Journal of virology.

[3]  R. Garcea,et al.  Expression of human papillomavirus type 11 L1 protein in insect cells: in vivo and in vitro assembly of viruslike particles , 1993, Journal of virology.

[4]  S. Stacey,et al.  Serological responses to HPV 16 in cervical dysplasia and neoplasia: Correlation of antibodies to E6 with cervical cancer , 1993, International journal of cancer.

[5]  M. Hagensee,et al.  Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by coexpression of the L1 and L2 capsid proteins , 1993, Journal of virology.

[6]  S. Stacey,et al.  Expression of human papillomavirus type 16 E6 protein by recombinant baculovirus and use for detection of anti-E6 antibodies in human sera. , 1992, The Journal of general virology.

[7]  F. X. Bosch,et al.  Antibodies to HPV-16 E6 and E7 proteins as markers for HPV-16-associated invasive cervical cancer. , 1992, Virology.

[8]  L. Crawford,et al.  Epitope-mapped monoclonal antibodies against the HPV16E1--E4 protein. , 1992, Virology.

[9]  D. McCance,et al.  Detection of antibodies to a linear epitope on the major coat protein (L1) of human papillomavirus type‐16 (HPV‐16) in sera from patients with cervical intraepithelial neoplasia and children , 1992, International journal of cancer.

[10]  M. Krcmar,et al.  Epitope mapping of the human papillomavirus type 16 E4 protein by means of synthetic peptides. , 1992, The Journal of general virology.

[11]  J. Dillner,et al.  Antigenic and immunogenic epitopes shared by human papillomavirus type 16 and bovine, canine, and avian papillomaviruses , 1991, Journal of virology.

[12]  I. Frazer,et al.  Expression of vaccinia recombinant HPV 16 L1 and L2 ORF proteins in epithelial cells is sufficient for assembly of HPV virion-like particles. , 1991, Virology.

[13]  R. Burk,et al.  Type-specific and cross-reactive epitopes in human papillomavirus type 16 capsid proteins. , 1991, Virology.

[14]  C. Crum,et al.  Pathobiology of papillomavirus-related cervical diseases: prospects for immunodiagnosis , 1991, Clinical Microbiology Reviews.

[15]  Michael A. Rodriguez,et al.  Detection of human papillomavirus types 6 and 11 E4 gene products in condylomata acuminatum , 1991, Journal of medical virology.

[16]  L. Brinton,et al.  Occurrence of IgA and IgG antibodies to select peptides representing human papillomavirus type 16 among cervical cancer cases and controls. , 1990, Cancer research.

[17]  J. Sundberg,et al.  Distribution and specific identification of papillomavirus major capsid protein epitopes by immunocytochemistry and epitope scanning of synthetic peptides. , 1990, The Journal of infectious diseases.

[18]  M. Krcmar,et al.  Synthetic peptides derived from E7 region of human papillomavirus type 16 used as antigens in ELISA. , 1990, The Journal of general virology.

[19]  R. Brasseur,et al.  Identification of seroreactive regions of the human papillomavirus type 16 protein E4, E6, E7 and L1. , 1990, The Journal of general virology.

[20]  J. Dillner Mapping of linear epitopes of human papillomavirus type 16: The E1, E2, E4, E5, E6 and E7 open reading frames , 1990, International journal of cancer.

[21]  J. Dillner,et al.  Mapping of linear epitopes of human papillomavirus type 16: The L1 and L2 open reading frames , 1990, International journal of cancer.

[22]  D. Patel,et al.  Identification of immunogenic regions of the major coat protein of human papillomavirus type 16 that contain type-restricted epitopes. , 1989, The Journal of general virology.

[23]  J. Doorbar,et al.  Sequence divergence yet conserved physical characteristics among the E4 proteins of cutaneous human papillomaviruses. , 1989, Virology.

[24]  H. Hausen,et al.  Papillomaviruses in anogenital cancer as a model to understand the role of viruses in human cancers , 1989 .

[25]  D. Galloway,et al.  Human antibodies react with an epitope of the human papillomavirus type 6b L1 open reading frame which is distinct from the type-common epitope , 1989, Journal of virology.

[26]  M. Stanley,et al.  Analysis of the L1 gene product of human papillomavirus type 16 by expression in a vaccinia virus recombinant. , 1988, The Journal of general virology.

[27]  M. Bunney Viral warts : their biology and treatment , 1982 .